Concepedia
Statistics
Publications
10
Citations
307
H-Index
Active since
2014
Affiliations
Keio University(Current)
Massachusetts General Hospital
National Hospital Organization
Tokyo Medical Center
Teikyo University
Aiko Nagayama is an author at Keio University specializing in oncology, medicine, and molecular oncology.
Publications per year
2014–2024
Comparative Effectiveness of Neoadjuvant Therapy for HER2–Positive Breast Cancer: A Network Meta-Analysis
Aiko Nagayama, Tetsu Hayashida, Hiromitsu Jinno et al. · JNCI Journal of the National Cancer Institute · 2014 · 69 citations
Medicine, Oncology, Pharmacology +16
PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer
Takehiro Yamamoto, Tetsu Hayashida, Yohei Masugi et al. · Cancer Research · 2024 · 51 citations · Full text
Life Sciences, Biochemistry, Oncology +15
Antibody–Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer
Aditya Bardia, Sheng Sun, Nayana Thimmiah et al. · Clinical Cancer Research · 2024 · 45 citations · Full text
Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
Ayako Nakashoji, Akira Matsui, Aiko Nagayama et al. · Oncology Letters · 2017 · 42 citations · Full text
Medicine, Oncology, Breast Oncology +13
Abstract 2638: Sacituzumab Govitecan, combination with PARP inhibitor, Talazoparib, in metastatic triple-negative breast cancer (TNBC): Translational investigation
Aditya Bardia, James T. Coates, Laura M. Spring et al. · Cancer Research · 2022 · 22 citations
Medicine, Oncology, Pharmacology +17
1–5 of 10